PRL and endothelial dysfunction: In vitro studies have also indicated that prolactin plays a role in the development of endothelial dysfunction in atherosclerosis through its ability to modulate the inflammatory response, stimulate vascular smooth muscle cell proliferation, and regulate mononuclear cell adhesion to the endothelium [53].